Expertise in
24
conditions

Dr. Lambros Stamatakis

Urology
MedStar Health: Urology At Brandywine
13950 Brandywine Rd, 
Brandywine, MD 
Accepting New Patients
Offers Telehealth
Expertise in
24
conditions
MedStar Health: Urology At Brandywine
13950 Brandywine Rd, 
Brandywine, MD 

Overview

Lambros Stamatakis is a Urologist practicing medicine in Brandywine, Maryland.

Dr. Stamatakis is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

He is actively involved in clinical research, co-authoring 46 peer reviewed articles and participating in 4 clinical trials. Dr. Stamatakis is currently accepting new patients.

Specialties

Urology

Licenses

Urology in MD

Hospital Affiliations

Medstar Georgetown University Hospital
Medstar Washington Hospital Center
Medstar Saint Mary's Hospital
Adventist Healthcare Shady Grove Medical Center
Medstar Southern Maryland Hospital Center

Languages Spoken

English
Greek

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

MedStar Health: Urology at Brandywine
13950 Brandywine Rd, Brandywine, MD 20613

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Intravesical Gemcitabine and MK-3475 (Pembrolizumab) in the Treatment of Patients With BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: August 11, 2026
Intervention Type: Procedure, Drug, Biological
Study Drugs: Gemcitabine Hydrochloride, Pembrolizumab
Study Phase: Phase 2
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Improving Surgical Care and Outcomes in Older Cancer Patients Through Implementation of an Efficient Pre-Surgical Toolkit (OPTI-Surg)
Enrollment Status: Active_not_recruiting
Publish Date: April 30, 2026
Intervention Type: Other
Study Phase: Not Applicable
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
S1602, A Phase III Randomized Trial to Evaluate the Influence of BCG Strain Differences and T Cell Priming With Intradermal BCG Before Intravesical Therapy for BCG-Naive High-Grade Non-muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: March 23, 2026
Intervention Type: Biological, Other
Study Drugs: Bacillus of Calmette-Guerin, Bacillus of Calmette-Guerin Tokyo-172 Strain Solution, Bacillus of Calmette-Guerin Tokyo-172 Strain Vaccine
Study Phase: Phase 3
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
View 3 Less Clinical Trials

46 Total Publications

Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review.
Synchronous papillary renal neoplasm with reverse polarity and multilocular cystic renal neoplasm of low malignant potential in unilateral kidney: case report with molecular analysis and literature review.
Journal: Frontiers in oncology
Published: April 03, 2025
Similar Doctors
Expertise in
35
conditions
Expertise in
35
conditions
Referral may be required

Chesapeake Urology Associates (Hanover)

7580 Buckingham Blvd, Ste 110, 
Hanover, MD 
 (32.7 miles away)
410-760-9400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rian Dickstein is a Urologist practicing medicine in Hanover, Maryland. Dr. Dickstein is highly rated in 35 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Hydronephrosis, Ureteroscopy, and Nephrectomy. Dr. Dickstein is board certified in American Board Of Urology - Urology, 2014 and The American Board Of Urology - Urology. Dr. Dickstein is currently accepting new patients.

Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required
Before you request

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10803 Falls Road, Pavilion III STE 3300, 
Lutherville, MD 
 (52.7 miles away)
410-955-6100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Arthur Burnett is a Urologist practicing medicine in Lutherville, Maryland. Dr. Burnett is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Priapism, Erectile Dysfunction (ED), Peyronie Disease, Prostatectomy, and Penectomy. Dr. Burnett is board certified in American Board Of Urology. Dr. Burnett is currently accepting new patients.

Expertise in
17
conditions
Expertise in
17
conditions
Referral may be required
Before you request

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10803 Falls Road, Pavilion III STE 3300, Pavilion III STE 3300, 
Lutherville, MD 
 (52.7 miles away)
410-955-6100
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Brian Matlaga is a Professor of Urology at Johns Hopkins University School of Medicine and also is the Director of the Stephens Center for Stone Disease as well as the Executive Vice Chair of the James Buchanan Brady Urological Institute. Dr. Matlaga is an internationally recognized expert in the medical and surgical management of patients with urinary stone disease. A frequent contributor to the medical press, with over 180 peer-reviewed publications, Dr. Matlaga’s research has received national and international awards. Dr. Matlaga sits on numerous editorial boards as well as advisory committees and guidelines panels for the American Urological Association, the American Board of Urology, the Endourological Society, and the National Institutes of Health, amongst others. Dr. Matlaga serves as Executive Medical Director of Clinical Affairs for Johns Hopkins Medicine International, the arm of Johns Hopkins Medicine that manages its global presence. In this capacity, he delivers clinical care as well as project leadership across the globe. Dr. Matlaga is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Kidney Stones, Bladder Stones, Boils, Ureteroscopy, and Lithotripsy. Dr. Matlaga is board certified in American Board Of Urology. Dr. Matlaga is currently accepting new patients.

Frequently Asked Questions about Dr. Lambros Stamatakis

How do I make an appointment with Dr. Lambros Stamatakis?

You can book an appointment with Dr. Lambros Stamatakis by calling their office at 301-782-2220. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lambros Stamatakis a top-rated expert for Bladder Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lambros Stamatakis is classified as an Elite expert for Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lambros Stamatakis specialize in?

While Dr. Lambros Stamatakis is a Urology, they have specific expertise in Bladder Cancer, Urothelial Cancer, and Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Urology.

Does Dr. Lambros Stamatakis participate in research or clinical trials?

Yes. Dr. Lambros Stamatakis has published 46 articles and abstracts on conditions like Bladder Cancer. You can view a list of Dr. Lambros Stamatakis's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Lambros Stamatakis accept my insurance?

Dr. Lambros Stamatakis accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 301-782-2220 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Stamatakis's expertise for a condition
ConditionClose
View All 18 Advanced Conditions
View All 32 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile